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Adverse pregnancy outcomes entail a large health burden for the mother and offspring; a part of it might be
avoided by better understanding the role of environmental factors in their etiology. Our aims were to review the as-
sessment tools to characterize fecundity troubles and pregnancy-related outcomes in human populations and their
sensitivity to environmental factors. For each outcome, we reviewed the possible study designs, main sources of
bias, and their suggested cures. In terms of study design, for most pregnancy outcomes, cohorts with recruitment
early during or even before pregnancy allow efficient characterization of pregnancy-related events, time-varying
confounders, and in utero exposures that may impact birth outcomes and child health. Studies on congenital anom-
alies require specific designs, assessment of anomalies in medical pregnancy terminations, and, for congenital
anomalies diagnosed postnatally, follow-up during several months after birth. Statistical analyses should take
into account environmental exposures during the relevant time windows; survival models are an appropriate ap-
proach for fecundity, fetal loss, and gestational duration/preterm delivery. Analysis of gestational duration could dis-
tinguish pregnancies according to delivery induction (and possibly pregnancy-related conditions). In conclusion,
careful design and analysis are required to better characterize environmental effects on human reproduction.
birth weight; cohort studies; congenital abnormalities; environment; fecundity; fetal membranes, premature rupture;
pregnancy; preterm birth
Abbreviations: PROM, premature rupture of the fetal membranes; TTP, time to pregnancy.
INTRODUCTION
Human reproduction occurs through a complex chain of
behavioral and biological events involving 3 individuals. Al-
though apparently inessential to the health of individuals, re-
production is crucial for the survival of the species. In
addition, perturbations in speciﬁc stages of reproduction
can have an important health impact: A major health concern
related to pregnancy is the rate of perinatal and maternal
deaths. There have been important declines in these rates
over the last decades in Western but not in all countries (1).
Another major health concern is preterm delivery, which is
associated with increased neonatal morbidity and mortality
and also has long-term consequences, such as increased risk
of neurodevelopmental and behavioral adverse events (cere-
bral palsy and cognitive and school difﬁculties), or altered pul-
monary function in childhood and adolescence (2). Fecundity
represents another important issue, because involuntary infer-
tility concerns a large proportion of pregnancy attempts (prob-
ably around 15%–25% of pregnancy attempts in the case of
12-month involuntary infertility) (3, 4), entails psychological
suffering (5), and may be associated with medical treatments
with limited efﬁciency and potential negative effects on ma-
ternal health. Birth weight is associated with many adult ill-
nesses (6). This association may not be causal but rather may
be explained by restricted fetal growth and adult diseases
sharing common causes such as environmental exposures
during development, as considered in the context of the de-
velopmental origins of health and disease (DOHaD) hypoth-
esis (6). This hypothesis, which highlights the importance of
development as a window of heightened sensitivity to stress-
ors, as well as the burden entailed by adverse fecundity and
pregnancy outcomes, warrants for a better understanding of
the impact of environmental exposures during pregnancy.
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Hundreds of studies (reviewed, e.g., in 7–10) have identi-
ﬁed environmental factors that possibly impact the occur-
rence of fecundity or pregnancy-related outcomes in humans.
The study of such potential impacts is made difﬁcult by meth-
odological challenges linked to the complexity of human re-
productive function (11–15). Such challenges include issues
related to the following: 1) the identiﬁcation of the population
at risk (the “right denominator”). For example, data on the
number of couples who resort to in vitro fertilization are dif-
ﬁcult to use to estimate trends in fecundity troubles without
knowledge on the number of couples at risk, that is, the num-
ber of pregnancy attempts; these couples cannot easily be
identiﬁed; 2) the fact that many reproductive life events are
not illnesses and, consequently, do not systematically require
contact with the health-care system; and 3) the interrelation
between the events from the start of a pregnancy attempt
until the delivery of a child, entailing complex selection phe-
nomena and “competing risks.” For example, an exposure in-
creasing the risk of spontaneous abortion will possibly limit
the proportion of surviving fetuses sensitive to the environ-
mental factor, which might in turn reduce the apparent impact
of this exposure on gestational duration, fetal growth, or fre-
quency of congenital anomalies.
Our aim was to review and discuss the assessment tools to
evaluate fecundity and pregnancy-related outcomes in human
populations and their sensitivity to environmental factors.
The health outcomes covered include fecundity troubles,
fetal loss and growth, congenital anomalies, premature rup-
ture of membranes, and preterm birth (Figure 1). Male (16)
or female fecundity parameters, sex ratio, pregnancy com-
plications, and postnatal health are out of the scope of this re-
view. Generally, exposure assessment can rely on biomarkers
assessed in (preferably prospectively collected) biological
samples (possibly in conjunction with toxicokinetic models,
when available), environmental models (for exposures oc-
curring via 1 main pathway, such as air or drinking water,
generally in conjunction with questionnaires on behaviors
inﬂuencing exposure), personal dosimeters, job-exposure
matrices, and questionnaires (17). Issues related to exposure
assessment (17) are discussed only if they are speciﬁc to the
ﬁeld of reproduction.
FECUNDITY AND TIME TO PREGNANCY
Definitions
Fecundity corresponds to the biological ability to obtain a
livebirth. We follow the demographic terminology that dis-
tinguishes fecundity from fertility, the actual number of live-
births of a woman (18). A quantitative estimate of fecundity
is fecundability, the cycle-speciﬁc probability for a couple
not using any birth control method and with regular sexual
intercourse to obtain a pregnancy (13, 19, 20). Time to preg-
nancy (TTP) (20) corresponds to the number of months (or
menstrual cycles) elapsed between the start and the end of
the period of unprotected intercourse (because of a preg-
nancy, because of the end of the relationship, or because
the couple no longer wishes to obtain a pregnancy). Note
that some authors deﬁne TTP for only the periods of unpro-
tected intercourse leading to a pregnancy, which we do not
recommend, following the common practice of survival anal-
ysis in which time periods not ending with the event of inter-
est should not be excluded, but rather censored. Involuntary
infertility is used to indicate that a couple has unsuccessfully
tried to obtain a pregnancy; it should be mentioned together
with a duration (e.g., 12-month involuntary infertility) (18).
Usually, fecundability (estimated by the proportion of cycle 1
conceptions) is in the 20%–30% range (Figure 2), while
15%–25% of couples are expected to suffer from 12-month
involuntary infertility (3, 4). Sterility corresponds to a biolog-
ical inaptitude to obtain a pregnancy. The diagnostic of ste-
rility requires medical examinations that can be difﬁcult to
systematically perform in the context of large population-
based cohorts; this outcome will not be considered here.
Figure 1. Overview of the timeline of pregnancy-related outcomes covered.
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Options for study design and outcome assessment
A straightforward estimate of fecundability at the popula-
tion level is the proportion of couples for which a pregnancy
starts during the ﬁrst month of unprotected intercourse. This
proportion, as well as the survival curve describing the cumu-
lative proportion of couples who obtain a pregnancy over
time, can be derived by assessing TTP (20). TTP also allows
one to estimate the frequency of involuntary infertility (e.g.,
using a Kaplan-Meier survival curve) if TTP has been as-
sessed for all pregnancy attempts, including those not leading
to a livebirth. TTP is usually assessed by a questionnaire. The
TTP study designs can be distinguished according to whether
couple identiﬁcation takes place before, during, or after the
period of unprotected intercourse (Figure 3). The latter
corresponds to the most frequent design and has among oth-
ers been used in the context of cohorts of pregnant women or
birth cohorts or of cross-sectional samples of women re-
cruited at the maternity clinic or sometime after delivery.
This so-called pregnancy-based design (21) has the advan-
tage of being the simplest from a logistic point of view, allow-
ing a large sample size, but the disadvantages that TTP is
assessed retrospectively (inducing measurement error) (22)
and that couples remaining infertile are excluded (giving
rise to a potential selection bias and underestimation of invol-
untary infertility rates). To avoid this, information on past pe-
riods of unprotected intercourse not leading to a pregnancy
can be retrospectively collected. Alternatively, recruitment
can also be performed before the start of the period of unpro-
tected intercourse (23, 24). In this incident cohort setting, an
option is the detailed prospective design; it implies collection
of information on timing of intercourse within each month,
menstrual bleeding, and a marker of ovulation (possibly
using devices monitoring urinary hormone metabolites,
such as home fecundity monitors) (24), thereby allowing
the making of inferences regarding the impact of environ-
mental factors on day-speciﬁc probabilities of conception
(25). Another design implies recruitment of couples during
the period of unprotected intercourse. If the couples are fol-
lowed up, then this corresponds to a prevalent cohort design;
if not, then the design is termed current duration (26, 27).
Whatever the design, an option relates to whether or not the
study should be restricted to ﬁrst pregnancy planners (see
below). The case-control study may be particularly prone to
selection bias when fecundity is the outcome in focus, be-
cause if cases correspond to couples resorting to infertility
treatments, controls should be sampled from the source pop-
ulation of these couples, which is difﬁcult to identify.
Main threats to validity
Sources of bias (21, 27–29) and possible remedies are in-
dicated in Table 1. The exclusion of infertile couples occur-
ring in the pregnancy-based design was formerly considered
as a minor issue (20); however, this exclusion can in some
situations strongly bias the estimated effect of exposure vari-
ables on time topregnancy (30–34).Several biases are related to
the complex notion of pregnancy planning (Table 1) (35). The
main issue is that, in the context where a relatively large pro-
portion of pregnancies are unplanned and hence excluded
from time to pregnancy studies because the outcome cannot
be assessed, bias may result if these couples with unplanned
pregnancy have a different distribution in terms of fecundity
(which is likely) and in terms of environmental exposures.
Recommendations
Design. The case-control design, if not nested within a
larger well-deﬁned cohort, should be avoided. The preferred
design for fecundability studies corresponds to recruitment
before the start of the pregnancy, allowing including couples
eventually remaining childless; this is achieved in the inci-
dent cohort, prevalent cohort, and current duration designs
(see above). A pregnancy-based design might entail bias
and a more limited statistical power for a given sample size
Figure 2. Evolution of the number of ongoing pregnancies, from the
start of a menstrual cycle, among 100 cycles (assuming that ovulation
occurs in 95 of these cycles). Approximate figures; slightly adapted
from Baird et al. (20).
Figure 3. Main designs for time to pregnancy studies (27). The start
date may be either the discontinuation of a method to avoid pregnancy
or the end of a pregnancy not followed by use of methods to avoid
pregnancy. The stop date may be the beginning of a pregnancy (de-
tected later), the resumption of any method to avoid pregnancy (con-
traception, sexual abstinence), or the initiation of medical treatment for
infertility. These last 2 situations correspond to censoring events. Du-
ration 5 (pregnancy-based design) is assessed only if a pregnancy is
detected at the end of the period of unprotected intercourse.
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Table 1. Main Sources of Bias in Studies of Environmental Impacts on Time to Pregnancy
Source of Bias Description of Potential Bias Possible Approaches to Limit Bias
Study design Exclusion of infertile couples (e.g., in a pregnancy-based design) (30–34) Consider alternative designs (incident or prevalent cohort, current duration
approach). In a population-based retrospective setting, try to collect information
on unsuccessful attempts at pregnancy.
Truncation (of short/long TTPs at the beginning/end of the study period,
respectively) (40, 106)
Define the study period with respect to the date of the beginning (and not the end)
of the period of unprotected intercourse; include current attempts.
Pregnancy planning bias 1: exclusion of unplanned/mistimed pregnancies Ascertain exposures for nonplanners as well and conduct sensitivity analyses
(21, 107).
Outcome
assessment
Pregnancy planning bias 2: unplanned pregnancies can retrospectively be
described as planned (also termed “wantedness bias”)
Reanalyze excluding declared cycle 1 conceptions. Define inclusion criteria on
contraceptive use rather than pregnancy wish.
Pregnancy planning bias 3: exclusion of couples who have unprotected
intercourse without planning to become pregnant
Try to include periods of unprotected intercourse corresponding to couples not
planning to become pregnant and reanalyze.
Pregnancy recognition bias: couples in whom pregnancy is diagnosed very early
may identify pregnancies ending with an early loss that would not have been
identified by other couples (21)
Record when and how pregnancy was recognized. Restrict analyses to
pregnancies leading to a livebirth.
Use of oral contraception may vary with exposure and might be associated with
decreased fecundability in the first cycles
Assess the last contraceptive method used; ask if couples used abstinence after
discontinuation of pill; treat pill use as time-varying covariate.
In a retrospective setting, couples may recall TTP with some error (e.g., digit
preference) (22)
Focus on pregnancies leading to a livebirth, for which recall may be better; group
consecutive TTP values (e.g., 5–7, 11–13 months).
Medical
intervention
Medical intervention bias: 1) medical treatments may modify the probability of
pregnancy; 2) if couples remaining childless are not recruited and if exposure is
associated with the delay before couples resort to medical help, bias may occur
Treat infertility treatment as a censoring mechanism; try to assess if infertility
treatments depend on exposure (conditionally on waiting time).
Exposure
assessment
Bias due to time trends in exposure and TTP: if, for example, TTP tended to be
longer at the start of the pregnancy period, and if exposure tended to decrease
over time, then a spurious association (corresponding here to an apparently
longer TTP in association with exposure) might be induced (28)
Simulate by using external data on the time trends in exposure (28).
Exposure is assessed during or after pregnancy instead of at the start of the period
of unprotected intercourse. Bias can occur if exposure varies quickly over time
(e.g., from month to month) or increases with time (creating a spurious
association with TTP)
Assess exposure at the start of the period of unprotected intercourse (38).
Behavior modification bias (if exposure is influenced by behaviors; for example,
couples may stop smoking after a delay of unsuccessful attempt at pregnancy)
Use date of discontinuation of contraception as a reference date to define
exposure and confounders. Assess modifications of behavior and use a model
with time-dependent covariates. Censor TTP (e.g., at 12 months).
Toxicokinetic bias (in studies relying on exposure biomarkers): bias due to
toxicokinetic changes in the body burden of the environmental factor following a
previous pregnancy (108)
Stratify analyses on parity (37).
Statistical
analysis
Proportional hazard hypothesis not verified Test for different effects of exposure during months 1–3 and 4–12 (or other cutoff)
of the pregnancy attempt.
Abbreviation: TTP, time to pregnancy.
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(32). However, if bias is limited (which is hard to know a pri-
ori), the loss in statistical power could be compensated by a
larger sample size, which is easier to achieve because of the
higher eligibility rate for this design compared with the other
ones; information on periods of unprotected intercourse not
leading to a pregnancy should also be collected in this retro-
spective design, which can be done if recruitment is not done
at a maternity clinic and if inclusion criteria are based on hav-
ing had a pregnancy or a period of unprotected intercourse
started in a given time period.
Effort should be made to collect information on couples
with unplanned or mistimed pregnancies, including on their
exposures and behaviors before the start of the pregnancy, to
discuss possible bias related to pregnancy planning (Table 1);
this is probably easier in the context of a pregnancy-based ap-
proach than for other designs.
It might be relevant to restrict time to pregnancy studies to
couples with no previous pregnancy or pregnancy attempt;
reasons for such a choice include 1) the fact that recruiting
already fertile couples will tend to overrepresent the most fe-
cund ones—even in societies with wide access to contracep-
tion, there is a rather weak but real association between time
to pregnancy and family size (36)—and 2) that, in studies in
which exposure is assessed with biomarkers, past pregnan-
cies and breastfeeding before the period of unprotected inter-
course under study will impact the measured levels of
biomarkers before the period of unprotected intercourse in
a way that is dependent on past reproductive history and pos-
sibly fecundity level. This issue has been highlighted in a
study of perﬂuorinated compounds on fecundity, in which
an increased risk of subfecundity in association with expo-
sure has been observed in parous but not nulliparous couples
(37). Blood levels of perﬂuorinated compounds are known to
decrease during pregnancy and lactation as the result of trans-
fer to the fetus (baby), as well as to a lesser extent through
increased renal excretion (increased glomerular ﬁltration
rate during pregnancy). The authors’ interpretation of the ob-
served association was that, in parous couples, the longer the
interpregnancy interval, the higher the potential for concen-
trations of perﬂuorinated compounds to increase again. Be-
cause, in parous couples, a long TTP will tend to increase
the interpregnancy interval, a bias toward an association be-
tween long TTP and high concentrations of perﬂuorinated
compounds (corresponding to reverse causality) could be
expected (37).
The main points on which TTP studies should collect in-
formation are indicated inWeb Appendix 1 available at http://
aje.oxfordjournals.org/.
Exposure assessment. The event of interest being the
occurrence of a pregnancy, the relevant exposure window
is some time before the start of the pregnancy (38). This
also applies to potential confounders (e.g., one should adjust
for smoking or age at the start of rather than after the period of
unprotected intercourse or during pregnancy). Information
on variations in exposure and in confounding factors during
the period of unprotected intercourse should be collected.
Statistical analysis. Statistical analysis of time to preg-
nancy data requires speciﬁc statistical approaches (e.g.,
discrete-time Cox model) and many sensitivity analyses
(21). This setting theoretically allows the handling of time-
varying covariates (e.g., if exposure varies during the period
of unprotected intercourse), although this has been applied
very little in TTP studies. Special attention should be given
to truncation bias (39, 40) and other sources of bias leading
to temporal trends in TTP (28); these may occur if inclusion is
based on the year of birth rather than the year of the start of the
period of unprotected intercourse. If couples with previous
history of pregnancy or pregnancy attempt are included, spe-
ciﬁc considerations are required; adjustment for this previous
history may not be relevant (41). Analyses stratiﬁed on parity
may be warranted to handle the above-mentioned speciﬁc is-
sues related to overselection of the most fecund couples and
to biomarker-based exposure assessment (37).
FETAL LOSS
Definitions
Fetal losses are deﬁned as a spontaneous end of pregnancy,
without living birth, occurring between conception and the
end of labor; in practice, because pregnancies cannot cur-
rently be detected until the time of implantation, this window
should be narrowed to the period between implantation and
the end of labor. Induced abortions and medical termination
of pregnancy are not considered as fetal losses, and neither
are ectopic pregnancies (corresponding to embryos im-
planted outside the uterus).
Fetal losses encompass a very heterogeneous and broad
continuum. The one end of this continuum corresponds to
a silent event occurring around the time of implantation (an
early fetal loss), while the other end of this continuum corre-
sponds to a stillbirth, with usually major psychological con-
sequences for the couple. The proximal causes of fetal losses
are also very heterogeneous with, for example, chromosomal
anomalies being much more frequent in ﬁrst compared with
second trimester spontaneous abortions (42).
The fetal loss continuum is subdivided into categories de-
ﬁned according to gestational age (Figure 4), starting from
early (or subclinical) fetal losses (between implantation and
the time of detection of the pregnancy, or within 6 weeks
from the last menstrual bleeding), spontaneous abortions
(sometimes referred to as miscarriages), and stillbirths. The
gestational age cutpoint between spontaneous abortions and
stillbirths has different legal deﬁnitions according to national
rules for registering births (43) and varies between 20 and 28
weeks. In epidemiologic studies, the cutpoints at 20 or 22
gestational weeks are most often used.
Because conception is difﬁcult to identify prospectively
outside the setting of in vitro fertilization, and because
early fetal losses are not accompanied by clinical signs
other than vaginal bleeding, the frequency of early fetal
loss is difﬁcult to quantify. Overall, fetal losses (from im-
plantation onward) may occur in about 20%–30% of all con-
ceptions (44–46); most of these (about two thirds) remain
undetected by couples (Figure 2). The frequency of sponta-
neous abortions typically corresponds to 10%–15% of iden-
tiﬁed pregnancies in women younger than 35 years (11). In
Europe in 2010, stillbirths corresponded to about 0.3%–
0.9% of detected pregnancies if medical terminations are
counted as stillbirths (47).
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Options for study design and outcome assessment
Study design will depend on the type of fetal loss in focus.
Except for stillbirths, cohort studies are a relevant setting.
Questionnaires are not adapted to assess early fetal loss oc-
currence, as they identify a very small proportion of the
fetal losses occurring before 6 gestational weeks, among
women who detected very early that they were pregnant,
who may constitute a selected group. For this outcome, reg-
ular (e.g., daily) urine sampling of women attempting to be-
come pregnant to assay human chorionic gonadotropin levels
can be performed to identify a rise in its level (which typi-
cally occurs 7–11 days after conception (48)) and possibly
a drop in the level (usually followed by vaginal bleeding),
as a biological measure of early pregnancy loss (46, 49). A
group of sterile women may be used to efﬁciently deﬁne
the threshold of human chorionic gonadotropin concentration
indicative of a pregnancy start (50).
Outside the context of assisted reproduction techniques,
some studies relying on couples planning to start a pregnancy
attempt have been conducted to study early losses (46, 49, 51,
52); such couples are difﬁcult to recruit, apart from excep-
tional situations such as that of China, where couples have
to register before planning a pregnancy (49).
Spontaneous abortions and stillbirths are usually detected
by either the woman herself or her clinician, for example,
via ultrasound, and a questionnaire-based approach can be
used. Studies relying on clinical data from the maternity
ward to identify fetal losses only allow identiﬁcation of the
subgroup of fetal losses leading to an admission to the hospital.
Prospective studies require identiﬁcation of women (or at least
a large number of them) before the end of the ﬁrst trimester, if
possible between 6 and 10weeks after the last menstrual bleed-
ing, and their follow-up (53). For stillbirths, recruiting women
before the end of the second trimester may be sufﬁcient.
Main threats to validity
The main sources of bias are listed in Table 2. Many of
them are related to the fact that there are variations in the ges-
tational age at pregnancy recognition or at inclusion. These
variations may, for example, be due to women pregnant as
a result of a failure in birth control methods detecting the
pregnancy later than those actively seeking to become preg-
nant. These variations in the gestational age at pregnancy
recognition will lead to some losses not being included (cor-
responding to left truncation in the terminology of survival
modeling) and to differences in the observed time at risk be-
tween women; this may lead to bias, in particular if these var-
iations are related to exposure (54).
Recommendations
Study design. Cohorts with recruitment as early as pos-
sible during (or before) pregnancy appear as a relevant design
for studies of environmental inﬂuences on the risks of spon-
taneous abortion and stillbirth. If early fetal losses are the
focus, then recruitment should take place before the begin-
ning of the pregnancy, and biological samples should be col-
lected on a daily or almost daily basis. In this setting, trying to
obtain information on couples who became pregnant without
planning it, by separately recruiting a group of such couples
with unplanned pregnancies, may be relevant to discuss any
bias resulting from their exclusion from the main analysis
done on the couples recruited before the beginning of the
pregnancy.
Exposure assessment. Only exposures before or during
the time period when the type of fetal losses considered can
occur should be considered; because the duration of the preg-
nancy varies according to its outcome, the probability for ex-
posure to occur or to be detected may differ according to the
Figure 4. Definition of fetal loss and infant mortality categories expanded from Wilcox et al. (14).
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pregnancy outcome, possibly leading to bias, as discussed for
another pregnancy outcome (55). Similar issues will occur if
exposure is not assessed as a binary but as a continuous vari-
able, such as a pregnancy average. This time-related bias can
be handled in the statistical analysis (see below) if information
on variations in exposure during pregnancy has been collected.
Statistical analysis. Statistical analysis of fetal loss must
use survival models to take into account left truncation (due
to losses occurring prior to enrollment) and right censoring
(54, 56). Right censoring (or possibly competing risk mod-
els) is required to handle induced abortions and medical preg-
nancy terminations. The use of such approaches requires
information on the date of identiﬁcation of the pregnancy.
Adjustment for reproductive history (e.g., previous history
of spontaneous abortion) should not be systematically per-
formed and may even induce a bias (41, 57), nor is a variable
identifying “usual aborters” relevant in analyses (58). Al-
though including past reproductive history in a regression
model can generally increase its ability to predict future re-
productive history (and hence the model ﬁt), past reproduc-
tive history does not always correspond to a confounder (in
particular if a past adverse pregnancy outcome had been
caused by a persistent exposure corresponding to that under
study) (59). Howards et al. (57) illustrate that a careful deﬁ-
nition of the research question and a representation of the hy-
pothesized causal relations among exposure, outcome, and
past reproductive history (e.g., through a directed acyclic
graph) are helpful to identify when adjustment for past repro-
ductive history, and possibly past exposures, is required.
Additional analyses describing any association between ex-
posure levels and the gestational age of detection of the preg-
nancy can be useful to discuss potential bias.
CONGENITAL ANOMALIES
Definitions
The deﬁnition of congenital anomalies classically includes
structural malformations, syndromes, functional defects, and
chromosomal anomalies present in the fetus or the newborn,
as deﬁned by the International Classiﬁcation of Diseases,
10th Revision (ICD-10), codes Q00.0–Q89.9.
Embryos affected by an anomaly may spontaneously abort
before clinical recognition of pregnancy, be identiﬁed during
prenatal screening (followed or not by pregnancy termina-
tion), or be detected at birth (in live- or stillbirths) or later
in life. The presence of anomalies in aborted embryos is ex-
pected to be frequent because malformations are a major
cause of abortion (60) and because chromosomal anomalies
(a proximal cause of malformations) are also a major cause of
abortion (42). Depending on the study design, only a subset of
all conceptuses affected by anomalies are usually identiﬁed.
Because of this potential for missed diagnoses, the fre-
quency of anomalies is usually measured by a prevalence
rate, expressed as percent births (even if anomalies are not
all detected at birth). The overall prevalence is around 2%
when only major anomalies are selected and may be much
higher when minor forms are included (15, p. 1079; 61). Spe-
ciﬁc types of major anomalies (neural tube defects, oral clefts,
severe hypospadias . . .) touch a few births per thousand.T
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Options for study design and outcome assessment
Because of the low prevalence of single categories of con-
genital anomalies (a few per thousand births), the preferred
study design has traditionally been a case-control approach.
Registers of congenital anomalies have been set up in many
countries and generally provide the basis for identiﬁcation of
cases. Registers distinguish major and minor anomalies and
often register only the major ones. The deﬁnition, diagnosis,
and reporting of minor anomalies vary considerably across
registries (62). As an example, until recently, glanular (or cor-
onal) hypospadias (a malformation in which the urinary
opening is misplaced on the glans) was not considered a
major anomaly by the European Registration of Congenital
Anomalies and Twins (EUROCAT) and consequently not
uniformly registered (63). Similar difﬁculties exist for crypt-
orchidism, the most frequent congenital anomaly in boys (64,
65). Both sensitivity and accuracy of the diagnosis of congen-
ital anomalies will depend upon the strategy of prenatal
screening, the classiﬁcation used (66), and the sophistication
of medical investigations. Screening procedures include ul-
trasonography and biochemical tests with a timing during
pregnancy that is usually deﬁned by the national screening
policies. The ﬁnal diagnosis is based on clinical examination,
autopsy or surgical reports, and complementary investigations
such as echocardiogram, tomodensitometry, and cytogenetics.
As usual, the recruitment of controls needs to be carefully
designed. Consider a case-control study of air pollution ef-
fects on congenital anomaly. If cases and controls are
matched on birth date, possible differences in exposure distri-
bution between cases and controls will be underestimated be-
cause the date is a strong determinant of air pollution level. A
similar issue may occur if cases and controls are matched on
the maternity of birth, which will possibly limit the spatially
driven exposure contrasts between cases and controls.
Mother-child cohorts recruiting pregnant women early dur-
ing pregnancy can constitute the source population for nested
case-control analyses if cases of congenital anomalies have
been diagnosed during the follow-up or have been identiﬁed
through record linkage with congenital anomalies registries.
This design offers the greatest opportunities for the study of
the most frequent anomalies, such as cryptorchidism (67).
For persistent chemicals, measurement of exposure through
assay of chemicals in biological media likely to reﬂect expo-
sure during pregnancy, such as cord blood, placenta (68), or
meconium, can be applied to case-control studies (ideally,
nested in cohort studies to allow collection of biological sam-
ples before occurrence of outcomes). Related challenges in-
clude possible bias due to any impact of pregnancy duration
or from time since the last pregnancy on the biomarkers’ levels,
as exempliﬁed for fecundity studies (37), as well as difﬁculties
in collecting biological samples from pregnancy terminations
and children with anomalies diagnosed several weeks after
birth. Family triads (cases and their 2 parents) have also
been used to estimate gene-environment interactions (69).
In countries where registration of congenital anomalies
among births, stillbirths, and pregnancy terminations covers
a large population and is accurate and reasonably exhaustive,
ecological correlation (registry-based) studies at small geo-
graphical scale have been conducted (70). In addition to
issues in terms of exposure assessment, a limitation of such
studies is that few individual characteristics and behaviors are
recorded besides knowledge of the defect, sex of the baby,
parental postal address (usually at birth), and maternal age.
The time-series design generally allows one to characterize
short-term effects of exposure, which, because the window
of sensitivity to pollutants is more likely to be in the ﬁrst
months of pregnancy (see below), does not represent an ap-
pealing approach.
Main threats to validity
Potential biases are summarized in Table 3. Like for fetal
loss, a potential bias lies in variations in the duration of the
period of follow-up, a duration inﬂuencing the measured
prevalence of anomalies.
Recommendations
Study design. In cohort studies, ideally, timing of inclu-
sion in the cohort should occur before the median gestational
age of prenatal diagnosis in the corresponding country. Diag-
nosis of congenital anomalies should be performed at least in
medical terminations of pregnancy and preferably also in
stillbirths, in addition to livebirths. In some areas covered
by a birth defects registry, linkage of the cohort members
with records from this registry can provide additional data
to identify and characterize congenital anomalies.
Outcome assessment. To limit heterogeneity in out-
come assessment, cases of mild anomalies such as cryptor-
chidism can be distinguished according to whether or not
this condition requires surgical repair, although there may
also be variability in medical practices. Congenital anomalies
diagnosed after birth should be recorded with a follow-up of
at least 1 year. In the special case of some anomalies not lead-
ing to fetal death or medical termination of pregnancy, and
present at birth, a standardized protocol of assessment and re-
porting is advised.
Exposure assessment. The embryonic period of intra-
uterine development is highly sensitive to teratogens. Germi-
nal cells, especially spermatozoa, may be affected before
conception and result in affected fetuses. Assessing exposure
in early pregnancy and if possible before conception is there-
fore necessary. Moreover, when studying malformations of
speciﬁc organs, exposures during the time window of devel-
opment of the organ should be speciﬁcally considered (e.g.,
gestational weeks 3–7 in the case when heart defects are of
interest) (71).
GESTATIONAL DURATION AND PRETERM BIRTHS
Definition
Gestational duration corresponds to the time between the
ﬁrst day of the last menstrual period and birth. The median
duration of pregnancy has been estimated to be 40 gestational
weeks and 2 days, or 282 days (72). Dichotomous outcome
measures of gestational duration exist (Table 4), the most fre-
quently used being preterm births (below 37 completed ges-
tational weeks). Note that, in the 1919–1961 period and
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beyond, a birth weight below 2,500 g was used as an opera-
tional deﬁnition of preterm births (14).
Preterm birth occurs in 4%–13% of all births (while very
preterm births account for about 1% of all births) and is
associated with strongly increased perinatal mortality and
long-term morbidity (73). Preterm deliveries are heteroge-
neous in terms of assumed proximal causes or associated ma-
ternal conditions (ischemic placental diseases, infectious or
inﬂammatory context, . . .) and of clinical context (prema-
ture rupture of the chorioamniotic membranes, preterm
labor, induced labor, or cesarean section for medical indica-
tions, e.g., to try to protect the mother or the fetus) (74). A
classiﬁcation of preterm births relying on 5 components
has been proposed (75). These components are as follows:
1) the maternal conditions present before presentation for de-
livery (e.g., infection, preeclampsia); 2) the fetal conditions
present before presentation for delivery (intrauterine growth
restriction, polyhydramnios, . . .); 3) placental pathologic
conditions; 4) signs of the initiation of parturition (cervical
shortening, premature rupture of membranes, . . .); and
5) pathway to delivery (spontaneous or induced).
Options for study design and outcome assessment
Outcome assessment. Outside the context of medically
assisted reproduction, fertilization is a silent event, so that the
date of conception is most often estimated retrospectively and
rarely knownwith accuracy. Gestational age can be deﬁned in
3 ways: 1) from the date of the last menstrual period, which is
usually collected retrospectively by questionnaire during
pregnancy or after birth, by the medical staff or speciﬁc ques-
tionnaires; 2) from ultrasound measures in early pregnancy,
making use of the property that speciﬁc fetal measures vary
linearly and rather homogeneously in the very beginning of
pregnancy, and that these ultrasound measures (e.g., biparie-
tal diameter or crown-heel length) can be used as a proxy for
gestational duration, using growth standards that are now re-
corded in the ultrasound devices; and 3) from a third (mixed)
approach, in which ultrasound measures are used to correct
the questionnaire-based date of the last menstrual period,
when the discrepancy between the 2 approaches exceeds a
given threshold (e.g., 2 weeks). Not treating preterm delivery
as a single entity is relevant; as an illustration, maternal
smoking seems to decrease the risk of very preterm deliveryT
ab
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Table 4. Main Cutoffs Used in the Study of Gestational Duration
Definition
Cutoffa
No. of Weeksb No. of Days
Extremely premature birth <28 <196
Very preterm birth <32 <224
Preterm birth <37 <259
Term birth 37–41 259–293
Postterm birth ≥42 294
a Since the end of the last menstrual period.
b Completed gestational weeks, corresponding to the integer part of
(date of birth− date of last menstrual period)/7.
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with a hypertensive context but to increase the risk of preterm
delivery associated with other pregnancy-related conditions
(76). Finer distinctions between subtypes of preterm deliver-
ies, possibly relying on the components outlined above, may
be a relevant option for future studies.
Study design. The case-control approach should be re-
served to the rarest forms of preterm delivery, such as very
preterm birth. Cohorts of pregnant women allow the greatest
ﬂexibility in terms of statistical analysis and assessment of
exposures and underlying conditions. Time series are another
option (77), depending on the exposure considered, if this ex-
posure has short-term variations and is expected to have
short-term effects. The use of case-crossover methods to
study acute triggers of preterm birth has also been proposed
(78, 79).
Main threats to validity
The main sources of bias in studies of gestational duration
are summarized in Table 5. The last menstrual period–based
approach suffers from (generally random) recall errors in the
estimation of the date of the last menstrual period and from
misclassiﬁcation errors due to between-women or within-
woman variations in the duration of the ﬁrst phase of the
menstrual cycle (80). If the studied exposure inﬂuences men-
strual cycle duration or regularity, this error will be differen-
tial according to exposure, so that measurement error in
gestational duration based on the last menstrual period may
also differ according to exposure. Although the ultrasound-
based deﬁnition of the date of fertilization is the most efﬁ-
cient one in predicting the date of birth (81), it is probably
not the most relevant for etiologic studies aiming at identify-
ing the inﬂuence of environmental factors on gestational du-
ration (15). Indeed, this approach relies on the assumption
that fetal growth (e.g., of biparietal diameter or femoral
length) is similar for all fetuses during the ﬁrst trimester of
pregnancy. It has been shown that this assumption does not
hold (82). If the environmental factor studied impacts on fetal
growth during the ﬁrst trimester of pregnancy, then the error
in the estimated gestational age based on ultrasoundmeasures
will possibly depend on exposure (Figure 5), so that the less
accurate but also less prone to bias measure based on the last
menstrual period could then be preferred (15).
Recommendations
Outcome assessment. Information on gestational dura-
tion should be collected by using both the deﬁnition based
on the date of the last menstrual period and on the ultrasound
measures, and sensitivity analyses relying on these different
approaches should be conducted. When one has to rely on the
hospital records to estimate gestational duration, it is impor-
tant to understand which approach is generally used by the
local practitioners. Gestational duration is counted in com-
pleted weeks (i.e., rounded to the closest lower integer) in
the clinical setting, but this is a considerable loss in informa-
tion, and a continuous measure should be preferred (in partic-
ular if gestational duration is to be analyzed as a “continuous”
outcome, or as an adjustment factor in the study of birth T
ab
le
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weight). Detailed information on the onset of labor (natural or
induced; reason of induction) should also be collected.
Issues related to exposure. When preterm birth is the
outcome of interest, exposures after gestational week 37 in
noncases should not be taken into account (as they are poste-
rior to the possible period of occurrence of the outcome of
interest).
Statistical analysis. Because what is actually studied is
the occurrence of a delivery and because censoring events
(e.g., speciﬁc medical intervention) occur, survival models
(rather than logistic regression of preterm delivery as a binary
outcome) should be considered as the default option in stud-
ies not relying on a case-control design (55). Induced deliv-
eries with speciﬁc causes can be handled as censoring (or
competing) events in the survival model. Preterm deliveries
with different underlying pregnancy-related conditions could
be considered separately. The continuous (linear regression)
analysis is tempting when the number of cases of preterm de-
liveries is limited; one should, however, keep in mind that
mean gestational duration (which is modeled in linear regres-
sion) will be strongly inﬂuenced by variations in gestational
duration in the range of 38–41 weeks, where most pregnan-
cies are. These variations may be driven by factors unrelated
to the frequency of preterm delivery, such as local habits in
terms of delivery induction and of handling of postterm
births, which strongly vary between countries. Quantile re-
gression, allowing the modeling of, for example, the 10th
percentile of gestational duration, might be a better option
than linear regression. Sensitivity analyses using the various
deﬁnitions of gestational durations should be performed, to
see if the estimated impact of environmental factors on ges-
tational duration or on the risk of preterm birth varies accord-
ing to the deﬁnition used.
PREMATURE RUPTURE OF THE FETAL MEMBRANES
Definition
Premature rupture of the fetal membranes (PROM) is de-
ﬁned as the spontaneous rupture of the amniotic membranes
before 37 weeks of gestation, at least an hour before the onset
of contractions. PROM occurs in approximately one third of
all preterm births (83). If left untreated, PROM will lead to
onset of labor, possibly causing miscarriage or preterm deliv-
ery. Apart from the risk posed by preterm delivery, amnion-
sac infections due to ascending microbes from the genital
tract are a major possible consequence of PROM. Further-
more, the absence of amniotic ﬂuid increases the risk of
fetal postural deformities and pulmonary hypoplasia.
Options for study design and outcome assessment
The diagnosis is set by a vaginal inspection where ﬂuid
containing meconium or vernix is observed coming through
the cervix. Also, increased pH in the upper vagina (a sign of
possible presence of amniotic ﬂuid) may be tested by nitra-
zine yellow. Immunoassays for amniotic-speciﬁc proteins
are also available. A reduced amount of amniotic ﬂuid (oligo-
hydramnion) cannot be used as a diagnostic criterion because
it is not speciﬁc to PROM.
Main threats to validity
Related to study design. Retrospective studies (i.e., with
postnatal recruitment) suffer from classiﬁcation errors, in par-
ticular if researchers have no access to medical records to
identify the existence of PROM.
Related to technique used to assess outcome. Misclassi-
ﬁcation occurs because of the subjectivity of the symptoms
and the low sensitivity of diagnostic techniques for conﬁrma-
tion of rupturedmembranes. Leakage of urine, aswell as vagi-
nal discharge, is commonly experienced during pregnancy
and may be mistaken for amniotic ﬂuid. Reciprocally, leak-
age of amniotic ﬂuid may occur slowly and in small amounts
and then be misinterpreted as urine or cervical discharge (84).
Errors tied to estimation of gestational age, previously out-
lined, may cause errors in classiﬁcation of PROM.
Recommendations
Outcome assessment. Immunology-based techniques
should be used; a physician diagnosis corresponds to the min-
imum requirement. Maternal reports should not be relied on
because of the high likelihood of misclassiﬁcation.
Statistical analysis. The heterogeneity of PROM (e.g.,
infectious, physical, cone-chirurgic related) may make it rel-
evant to perform separate subanalysis of mothers according
to the existence of these predisposing factors; physical
Figure 5. Illustration of the bias possibly occurring in studies of en-
vironmental effects on fetal growth, when gestational age is defined by
early ultrasound measures (96). Hypothetical evolution of a fetal mea-
surement (e.g., fetal length) during pregnancy, for a pregnancy ex-
posed or unexposed to an environmental factor affecting fetal
growth from early pregnancy. The ultrasound examination leads the
obstetrician to correct the date of conception of the exposed preg-
nancy by Δt, so this exposed pregnancy is not compared with unex-
posed pregnancies with the same gestational age D (solid curve) as
should be the case but with gestational age D − Δt (dashed curve).
Consequently, the estimated difference in the gestational age–specific
fetal measurement at birth between exposed and unexposed preg-
nancies is not the correct value β but a smaller value β0.
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(polyhydramnion, twins) and cone-chirurgic–related risk fac-
tors should be taken into account. Survival analysis is an op-
tion for statistical analysis. As for studies on gestational
duration, gestational age should preferably be estimated by
using both last menstrual period and ultrasound information,
because of the possibility of errors tied to both methods.
Issues related to exposure. In cases of slow amniotic
leakage, the starting point of PROM may be difﬁcult to as-
sess, and this must be kept in mind when evaluating whether
exposure truly occurred before (and not after) the onset of
PROM.
FETAL GROWTH AND SIZE AT BIRTH
Definition
Fetal growth is a continuous phenomenon taking place
throughout the pregnancy. The fetal weight gain is approxi-
mately 50 g during the ﬁrst trimester, 700 g during the sec-
ond trimester, and 2,500 g in the last trimester, to reach a
median birth weight at term around 3,000–3,500 g (85).
The proportion of low birth weights (<2,500 g) in Europe
and North America is in the range of 3%–10%, while it is
in the range of 10%–20% in the other continents; in Europe,
low birth weight accounts for about 1% of term births. Birth
weight is correlated with health status in life. Birth weight has
indeed been associated (after control for gestational duration)
with mortality from several chronic diseases, including circu-
latory diseases or causes other than cancer, as well as with
occurrence of neurological disorders in childhood and later.
Relations exhibited a J shape, the risk of disease decreasing
until about 4,000 g and increasing for higher birth weights
(14, 86). Cancer mortality, on the other hand, increases con-
tinuously with birth weight (86). As discussed by Wilcox
(14), this association may not be causal, which does not di-
minish the validity of birth weight as a nonspeciﬁc marker of
exposures and mechanisms taking place during development
(6, 87–89).
Different metrics have been used to identify fetal growth
determinants. All need to be corrected for the gestational du-
ration, which can be done directly or at the step of regression
modeling with weight determinants by statistical adjustment.
These metrics include continuous birth weight, low (<2,500 g)
or very low (<1,500 g) birth weight (possibly restricted to
term births), small for gestational age (corresponding to a
birth weight lower than the 10th percentile of a suitable
sex- and gestational age–speciﬁc weight reference distribu-
tion), intrauterine growth restriction (generally used equiva-
lently to small for gestational age), and fetal growth
restriction. The entity of “small for gestational age” newborns
fails at distinguishing “constitutionally small” infants—those
small because of parental anthropometric characteristics—
from those who are “growth retarded,” that is, smaller than
what their parental characteristics, parity, sex, and gestational
duration would predict. The deﬁnition of fetal growth restric-
tion is meant to address this limitation. Although a consensus
is lacking, a newborn is deﬁned as fetal growth retarded if it is
in the lower tail of the size distribution of fetuses with the same
gestational age, sex, parity, and maternal characteristics.
Birth weight is a summarymeasure that does not identify the
respective contributions of the different body parts. Other mea-
sures of neonatal anthropometry, such as length and head and
abdominal circumferences, provide additional information.
Birth weight is at the endpoint of intrauterine growth and,
as such, does not provide information on fetal growth or
growth velocity in speciﬁc gestational periods (90). In
order to identify possible periods of fetal growth restriction,
serial measures of fetal parameters, such as biparietal diam-
eter, head circumference, femoral length, and abdominal cir-
cumference by ultrasound, can be performed (91, 92).
Options for study design and outcome assessment
Study design. Unlike most previously discussed out-
comes, the quality of information on birth weight from hos-
pital records or questionnaire to the mother is usually good,
limiting outcome misclassiﬁcation in retrospective studies;
these studies may still suffer from exposure and confounder
misclassiﬁcation and, importantly, from heterogeneity and
error in assessment of gestational duration (refer to the Con-
clusion). Cohorts with prenatal recruitment (as early as pos-
sible, depending on the toxicologically relevant exposure
window) therefore represent the preferred option to limit po-
tential bias. Ultrasound examinations can be used to monitor
fetal growth (91, 92).
Main threats to validity
Related to study design. Compared with cohorts of preg-
nant women or of couples recruited before a pregnancy, stud-
ies with a postnatal recruitment might entail classiﬁcation
errors on potential confounders that need to be assessed dur-
ing pregnancy. This is, for example, the case for maternal
smoking during pregnancy (better assessed during than
after pregnancy) or prepregnancy weight.
Related to technique used to assess outcome and con-
founders. The approach used to deﬁne gestational age
may impact on the estimated effect of environmental factors
on birth weight; the last menstrual period–based deﬁnition
has been advocated if the exposure may impact fetal growth
(Figure 5).
Recommendations
Outcome assessment. Birth weight should be measured
just after birth, because from 24 to 72 hours after birth babies
tend to lose about 3%–10% of their weight. Newborn length
and head circumference, on the other hand, should be mea-
sured from 24 to 48 hours after birth as they could be distorted
by labor (recording also the exact date of the measure in order
to correct for the time elapsed between birth and the measure-
ments). Assessment of fetal growth by ultrasound measures
can be useful to detect possible transitory effects of exposures
on fetal growth. Information on who performed the measure
should be collected and, if possible, the design should allow
limiting the number of ultrasound operators and devices
used. Standardization workshops among ultrasonographers
prior to the study start are also encouraged. In addition to
fetal measures, the placenta can be weighed at birth to study
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any environmental inﬂuence on placental function (93–95), a
strong determinant of fetal growth and development.
Statistical analysis. Sensitivity analyses using different
deﬁnitions of gestational duration are advised (91, 96). Anal-
ysis of fetal growth using repeated ultrasound measures can
be done using a longitudinal approach (97, 98), possibly in
addition to repeated cross-sectional analyses (91, 99); the 2
main options are presented in Web Appendix 2. According
to toxicological data and biological plausibility, analyses
stratiﬁed on sex of the offspring can be considered a priori.
CONCLUSION
We have reviewed some of the tools allowing study of the
impact of environmental factors on human fecundity and re-
production. These may also, of course, apply to the study of
nonenvironmental factors. Our focus was on clinical out-
comes, but biomarkers of effect can also be assessed in spe-
ciﬁc tissues or with medical examinations, which can allow,
among others, discussion of pathways whereby environmen-
tal factors could impact fecundity and reproduction (e.g.,
inﬂammatory or epigenetic pathways). Some examples of
possibly useful tissues and examinations are given in Table 6.
Because the collection and analysis of biological samples are
logistically cumbersome and expensive (depending on the
exposure considered and the biochemical assays available),
they may not be the ﬁrst option for very rare exposures.
In terms of study design, cohorts with prenatal enrollment
constitute a good approach allowing characterization of po-
tential confounders, exposures (assuming that the relevant
time window is not before fertilization), and most pregnancy-
related outcomes. If children are followed up, this cohort
approach allows study of the longer-term consequences of
environmental exposures during the developmental window.
Recruitment in such cohorts is a crucial issue; it should take
place as early as possible, which is a logistical challenge in
many areas where women are not referred to a speciﬁc hospi-
tal in early pregnancy. Recruitment before conception would
be a good option to ensure efﬁcient characterization of peri-
conceptional exposures (and would additionally allow study
of fecundity in a prevalent cohort design), but recruitment of
couples shortly before a pregnancy is also a logistic chal-
lenge. The cohort design may be at odds for rare outcomes,
such as speciﬁc congenital anomalies, very preterm delivery,
or perinatal mortality, for which case-control, time-series (for
the 2 latter outcomes), and register-based studies (with more
Table 6. Biological Samples and Medical Examinations of Relevance for Studies on Environmental Impacts on Fecundity and Reproduction
Tissue or Examination Related Outcomes or Measures Examples ofReferences
Semen Male fecundity (sperm morphology, mobility, concentration, DNA
quality)
(112)
Ultrasound examination of ovaries and ovarian
reserve
Ovarian/menstrual function, ovarian structure (polycystic ovaries),
and fecundity
Urine Exposure biomarkers
Hormonal markers (49)
Metabolomics
Maternal blood Exposure biomarkers
Markers of inflammation, immunological and hormonal status,
glucose tolerance tests
(113)
DNA methylation, gene expression, metabolomics
Vaginal sample Vaginal microbiota, vaginosis
Ultrasound examination Fetal size and growth; possibly placental morphology (114)
Congenital malformations
Maternal blood pressure, electrocardiography Maternal cardiovascular function (115, 116)
Doppler examination of uterine, umbilical, or
fetal arteries
Blood flow, oxygen and nutriment supply (95)
Cord blood Exposure biomarkers (117)
Markers of inflammation, immunological and hormonal status
DNA methylation, gene expression, metabolomics
Amniotic fluid (if available) Exposure biomarkers (118)
Placental tissue DNA methylation (119)
Gene expression (120)
DNA content (121)
Vascularization/histology (122)
Exposure biomarkers (123)
Meconium Exposure biomarkers (124)
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ecological assessment of exposure) can be preferred to in-
crease the number of observations or cases. Electronic birth
registers, which exist in some areas, can indeed serve as a
basis for studies on speciﬁc pollutants whose levels can be
assessed by using simple information such as the home ad-
dress (100), but not when biomarkers are required to assess
exposure; they are particularly useful for the rare events men-
tioned above. It can, however, be noted that information on
home address may have poor accuracy (e.g., limited to zip
code or to the birth address without considering changes of
address during pregnancy); that the availability of potential
confounders is generally limited in such registers, which
may or may not (101) be an issue depending on the associa-
tion studied; and that information on clinical interventions
(such as elective cesarean sections, which occur in up to
one third or half of pregnancies in some areas (47)) may
not be available in such designs, which is a potential source
of bias as in studies on preterm delivery (see above). Two-
phase approaches can be used to limit issues related to miss-
ing information in register-based studies (102). Overall, on
the one hand, cohorts with prenatal enrollment have a larger
potential for selection bias (because of intense follow-up and
collection of biological samples), whereas register-based and
retrospective studies are more prone to measurement error
and confounding while allowing larger sample sizes. The
choice between these designs can be seen as an illustration
of the bias-variance trade-off and needs to be carefully dis-
cussed in relation to the considered exposure(s).
In terms of confounding, just like for other outcomes, all
factors statistically or biologically associated with the repro-
ductive outcomes should not be systematically adjusted for;
in particular, factors that are possible consequences of the ex-
posure or of the health outcome in focus are not confounders
(103). Following this line, whether a previous history of the
adverse pregnancy outcome being studied is a potential con-
founder should be discussed (41, 57). Directed acyclic graphs
constitute a relevant tool to discuss the choice of confounders
in reproductive epidemiology (57, 104).
We did not review exposure assessment, which is an issue
not speciﬁc to reproductive epidemiology, but listed biolog-
ical samples of relevance for assays of exposure biomarkers
(Table 6) and discussed speciﬁc sources of bias related to ex-
posure assessment. It can be noted that pregnancy and deliv-
ery are associated with strong changes in physiological
parameters (e.g., in terms of immunological status, energy
needs, metabolism, blood viscosity and volume, cardiovas-
cular function (105)), body weight and composition, and be-
haviors (e.g., smoking, home address, work and occupational
exposures, physical activity, diet), which may impact expo-
sure levels and may drastically increase the amplitude of
exposure misclassiﬁcation when exposure has not been as-
sessed in the “right” time window. Some of the factors may
also impact the body burden of speciﬁc environmental con-
taminants, increasing exposure misclassiﬁcation if, for exam-
ple, there is heterogeneity in previous reproductive history or
in the gestational age at which biological samples used to as-
sess exposure biomarkers are collected.
Serious consideration of these issues is relevant in order to
better characterize the impact of environmental factors on
human reproductive function.
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